BAYER AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.43 EUR | +0.51% |
|
+3.57% | -17.02% |
| 05-02 | European Equities Close Mostly Lower in Thursday Trading; Eurozone Manufacturing Remains in Contraction | MT |
| 05-02 | Manufacturing Downturn Keeps German Stocks Lower | MT |
| Sales 2024 * | 47.09B 50.63B 4,032B | Sales 2025 * | 47.95B 51.55B 4,105B | Capitalization | 27.64B 29.71B 2,366B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.08B 2.24B 178B | Net income 2025 * | 3.17B 3.41B 271B | EV / Sales 2024 * | 1.29 x |
| Net Debt 2024 * | 33.1B 35.59B 2,834B | Net Debt 2025 * | 29.67B 31.9B 2,541B | EV / Sales 2025 * | 1.2 x |
| P/E ratio 2024 * |
12.8
x | P/E ratio 2025 * |
8.65
x | Employees | 96,931 |
| Yield 2024 * |
0.39% | Yield 2025 * |
0.83% | Free-Float | 99.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Bayer AG
More press releases
| 1 day | +0.42% | ||
| 1 week | +3.57% | ||
| Current month | -1.74% | ||
| 1 month | -0.46% | ||
| 3 months | -6.78% | ||
| 6 months | -31.63% | ||
| Current year | -17.02% |
1 week
26.88
28.35
1 month
25.6728.90
Current year
24.9836.00
1 year
24.9859.50
3 years
24.9867.95
5 years
24.9879.00
10 years
24.98146.26
| Managers | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 31/03/23 |
| Director of Finance/CFO | 55 | 25/04/18 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/03/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 31/03/17 |
Alberto Weisser
BRD | Director/Board Member | 67 | 31/03/21 |
Paul Achleitner
BRD | Director/Board Member | 67 | 31/03/02 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/05/24 | 28 | -1.01% | 4 778 |
| 02/05/24 | 28.28 | +3.32% | 11,132 |
| 30/04/24 | 27.38 | -0.36% | 3,051 |
| 29/04/24 | 27.48 | -0.20% | 9,382 |
| 26/04/24 | 27.53 | +1.98% | 6,269 |
Delayed Quote Deutsche Boerse AG, May 03, 2024 at 01:20 pm
More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
14/05/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
28.13
EUR
Average target price
36.9
EUR
Spread / Average Target
+31.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.68% | 681B | |
| +20.34% | 556B | |
| -4.35% | 361B | |
| +17.65% | 325B | |
| +3.77% | 285B | |
| +14.58% | 235B | |
| +4.39% | 199B | |
| -11.29% | 189B | |
| -3.79% | 157B |
- Stock Market
- Equities
- BAYN Stock
- BAYN Stock
